DJ ReShape and Obalon Expect to Complete Merger After Market Close
By Josh Beckerman
ReShape Lifesciences Inc. and Obalon Therapeutics Inc., which focus on medical devices for weight loss, expect to complete their merger after the close of the market Tuesday.
Shares of Nasdaq-listed Obalon were recently up 7% to $3.47. OTCQB-listed ReShape was down 7% to $5.11.
The merged company's stock is expected to begin trading on the Nasdaq Capital Market Wednesday, under the ReShape name and symbol "RSLS."
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
June 15, 2021 14:30 ET (18:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.